Ccx282-B, an orally active inhibitor of chemokine receptor Ccr9, shows anti-inflammatory and clinical activity in the treatment of Crohn's disease

書目詳細資料
Main Authors: Keshav, S, Ungashe, S, Zheng, W, Belker, P, Wright, K, Schall, T
格式: Conference item
出版: 2007

相似書籍